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common time point where patients are identiﬁed, the
referral event.
This leads us to a second problem with deﬁnitions. As
indicated by de Borst, Rantner et al.3 recently reported that
acute carotid endarterectomy does not confer increased
procedural risk, in contrast to our earlier prospective anal-
ysis showing that very early carotid endarterectomy is
associated with increased risk.3 However, Rantner et al.3
deﬁned the index event as the latest event rather than
the event that resulted in referral, and we argue that this
difference could explain part of the discrepancy.4 Guidelines
state that patients seeking medical care for a neurological
event should receive immediate treatment with statins and
antiplatelet agents. A recent study showed that the risk of
recurrent stroke is lower in patients pre-treated with sta-
tins, and it is thus likely that the procedural risk is reduced
by medical treatment received in hospital.5 Thus, deﬁning
the index event as the most recent event may result in a
bias towards lower complication rates.
We agree that the beneﬁt with early (within 14 days)
carotid endarterectomy is proven. However, the advantage
of surgery within 2 days of a referring event is not clear and
could even be associated with higher risk than medical
treatment alone.
REFERENCES
1 de Borst GJ. The true risk of early recurrent stroke: importance
of cohort composition and index event deﬁnition. Eur J Vasc
Endovasc Surg 2015;49(2):145e6.
2 Stromberg S, Nordanstig A, Bentzel T, Österberg K,
Bergström GM. Risk of early recurrent stroke in symptomatic
carotid stenosis. Eur J Vasc Endovasc Surg 2015;49(2):137e44.
3 Rantner B, Schmidauer C, Knoﬂach M, Fraedrich G. Very urgent
carotid endarterectomy does not increase the procedural risk.
Eur J Vasc Endovasc Surg 2015;49(2):129e36.
4 Stromberg S, Gelin J, Osterberg T, Bergström GM, Karlström L,
Osterberg K. Swedish Vascular Registry (Swedvasc) Steering
Committee. Very urgent carotid endarterectomy confers
increased procedural risk. Stroke 2012;43(5):1331e5.
5 Merwick A, Albers GW, Arsava EM, Ay H, Calvet D, Coutts SB,
et al. Reduction in early stroke risk in carotid stenosis with
transient ischemic attack associated with statin treatment.
Stroke 2013;44(10):2814e20.
K. Österberg
Department of Vascular Surgery, Sahlgrenska University
Hospital, Gothenburg, Sweden
G.M.L. Bergström
The Sahlgrenska Centre for Cardiovascular and Metabolic
Research, Wallenberg Laboratory, Institute of Medicine, The
Sahlgrenska Academy at the University of Gothenburg,
Gothenburg, Sweden
S. Strömberg*
Department of Vascular Surgery, Sahlgrenska University
Hospital, Gothenburg, Sweden
The Sahlgrenska Centre for Cardiovascular and Metabolic
Research, Wallenberg Laboratory, Institute of Medicine, The
Sahlgrenska Academy at the University of Gothenburg,
Gothenburg, Sweden
*Corresponding author. Department of Vascular Surgery,
Sahlgrenska University Hospital, Gothenburg, Sweden.
Email-addresses: soﬁa.stromberg@vgregion.se,
soﬁa.stromberg81@gmail.com (S. Strömberg)
 2015 European Society for Vascular Surgery. Published by
Elsevier Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.ejvs.2015.03.038
DOI of original article: http://dx.doi.org/10.1016/
j.ejvs.2015.03.039
128 CorrespondenceRe: ‘The True Risk of Early Recurrent Stroke: Importance of
Cohort Composition and Index Event Deﬁnition’
In the individual patient with symptomatic signiﬁcant ca-
rotid artery stenosis there are two means of reducing the
overall risk of recurrent stroke: (i) by early recognition of
the presenting symptom and fast work up to perform
expedited carotid revascularization thus preventing recur-
rent events in the waiting time to surgery; and (ii) by per-
forming safe carotid revascularization.1,2
In recent years, in symptomatic patients with carotid
artery disease (CAD), the focus has been on early inter-
vention, to be performed as soon as possible but at least
within 2 weeks of presentation. To reach this 2 week
threshold and in order to score the effectiveness of the
center and specialist involved, the referral event is the
easiest and most practical starting point. However, in using
the referral event to assess the rate of recurrent events,
patients that suffered a recurrent stroke as secondary event
before referral may be missed, and as a consequence may
no longer be candidates for revascularization. These pa-
tients, with a second severe cerebral event prior to referral,
have been named “the lost cohort” as these patients are
often not included in studies on patients undergoing carotid
revascularization. By counting the very ﬁrst event as the
index event in patients with symptomatic CAD, it will be
possible to analyze the true risk of early recurrent stroke
and also include those that had their recurrent event prior
to referral. In doing so, the true impact of recurrent events
can become identiﬁable, and this has more relevance to the
overall prevention of stroke instead of reporting only the
events in patients scheduled for intervention.
The deﬁnitions “latest event”, “referral event”, or “most
recent event” all distract from what is most relevant to the
patient: recognition of the symptoms as being related to
severe CAD, needing urgent work up and expedited revas-
cularization. In order to protect as many patients as possible
it is therefore necessary to keep in mind that most recur-
rent events can be prevented when using the very ﬁrst
event as the index event for intervention. The clinical
Correspondence 129importance here is that if a person has a minor stroke or
transient ischemic attack, it is a major indicator that this
patient is at high risk of further stroke in the early days
following the event.3 For the future guidelines should apply
a universally agreed deﬁnition of the index event to make
reports of delay to carotid endarterectomy more
comparable.
Medication is able to stabilize the vulnerable plaque,
especially by reducing macrophage content and increasing
smooth muscle cells, but its relative contribution depends
on the type of index symptom and may take weeks to
become effective.4,5 It is not expected that statins can play
a major role when performing carotid revascularization
within days of ﬁrst contact. As the effect of medication on
plaque stabilization may take weeks there is no reason to
expect bias towards lower complication rates, especially as
dedicated medication is often started only after the ﬁrst
specialist contact initiating full therapy. Clearly, there is no
need to wait longer for the effect of medication to stabilize
the plaque as there is already an effective intervention to
reduce the risk of recurrent stroke, namely expedited ca-
rotid revascularization.6
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